Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis
ObjectiveProgestin based therapy is the preferred option for fertility-sparing treatment of reproductive-age women with preserved fertility in endometrial hyperplasia (EH) or early endometrial cancer (EEC). Our objective was to investigate whether metformin could enhance the efficacy of progestin-ba...
שמור ב:
| Principais autores: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Frontiers Media S.A.
2023-06-01
|
| סדרה: | Frontiers in Endocrinology |
| נושאים: | |
| גישה מקוונת: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1139858/full |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|